At last year’s BioPharma India Convention Shravanti Bhowmik, MD of Clinical Research at Sun Pharma Advanced Research Company delivered the presentation Biosimilars & Biobetters: Regulatory approval differences.
This presentation covers:
- Top 10 drugs of 2012
- Sales by product class and as a fraction of total US prescription drug sales
- Worldwide Biologics Status
- Current sales and estimated patent expiry of selected protein products
- Biosimilar development cost
- Biosimilar development timeline
- Biosimilar requirements
- Biosimilar Advantages
- Biosimilar challenges
- Biobetter Drivers
- Biobetters Challenges
- Biobetters in development
- Regulatory approval process
- Biosimilar Vs Biobetter